Opinion: Canadian Science Under Attack

Government policies are shuttering research facilities while muzzling federal researchers by dissuading them from talking to the press, participating in international collaborations, or publishing their work.

Written byHeather E. Douglas
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

IMAGE COURTESY OF WWW.SCIENCEUNCENSORED.CACanadian government science is under siege. The administration of Prime Minister Stephen Harper—first under the guise of creating a uniform message across the government, and more recently with the stated intent of controlling intellectual property and cost-saving—is dismantling the Canadian governmental science apparatus and its role in providing a source of accountability in Canadian democracy.

This erosion began in 2007 with the imposition of rules requiring that all public servants (including government scientists) get approval before speaking in public or to a journalist on any topic. These rules were rolled back for routine queries about the weather, but other than that, scientists were to check with media relations or communications officers before any public contact.

Of course, this in isolation is not a problem, except that the government made sure that such requests, particularly for potentially sensitive research (e.g. about the impacts of climate change), were met with slow bureaucracy, responses taking days or weeks, by which time the news cycle would have moved on.

Even more insidious, some approvals came with pre-determined talking points, boring bullets beyond which scientists ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies